Following the announcement of our successful assessment by the World Health Organization (BUSINESS WIRE), BioPharma Services was honoured today to be recognized by our Humber River-Black Creek MP, Judy Sgro in Question Time at the House of Commons.
The World Health Organization (WHO) completed a GCP/GLP/BE assessment of two clinical studies performed at BioPharma’s Toronto, Canada site and subsequently found BioPharma to be in compliance with WHO Good Clinical Practice & Guidance for in vivo bioequivalence studies. With this successful assessment, BioPharma received a status of Compliance valid through to the 1st of January 2021.
As Renzo DiCarlo, CEO shared this news with BioPharma’s clients and employees, he remarked, “This public recognition by Judy Sgro MP of BioPharma’s status as a global leader in medical research is certainly gratifying for our team. Being one of the few clinical research companies worldwide to have received certification by WHO is an outstanding achievement and along with our expertise in other areas such as Phase I and Human Abuse Liability trials, makes BioPharma the number one choice for clinical trials.”
About BioPharma Services Inc.
BioPharma Services Inc. is a fullservice Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma has clinical facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Medical Writing and Data Management.
Main Telephone: +1 844 747 8484
Ms. Anna Taylor, Executive Vice President, Business Development, BioPharma Services, Inc.